Section Arrow
SNTI.NASDAQ
- Senti Biosciences Inc.
Quotes are at least 15-min delayed:2026/02/22 06:56 EST
Regular Hours
Last
 0.86
-0.03 (-3.37%)
Day High 
0.942 
Prev. Close
0.89 
1-M High
1.19 
Volume 
230.23K 
Bid
0.855
Ask
0.87
Day Low
0.8534 
Open
0.9 
1-M Low
0.797 
Market Cap 
23.40M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.87 
20-SMA 0.95 
50-SMA 1.1 
52-W High 5.1 
52-W Low 0.797 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.87/-1.01
Enterprise Value
52.29M
Balance Sheet
Book Value Per Share
0.31
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.12
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CDIOCardio Diagnostics Holdings Inc.2.88+0.64+28.57%-- 
IBRXImmunityBio8.7+0.09+1.05%-- 
GERNGeron Corp1.88-0.04-2.08%-- 
QNCXQuince Therapeutics0.1501-0.0121-7.46%-- 
RXRXRecursion Pharmaceuticals3.42-0.3-8.06%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.